Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Best CJC-1295 No DAC Dosage Fat Loss 2026: Protocol Comparison

The following table compares the three most common CJC-1295 no DAC dosing strategies for fat loss based on clinical data and real-world research applications: | Protocol | Daily Dose | Administration Frequency | Typical GH Pulse Amplitude (vs Baseline) | Fat L

This comparison does not assign a generated winner or score.

  • The following table compares the three most common CJC-1295 no DAC dosing strategies for fat loss based on clinical data and real-world research applications:
  • | Protocol | Daily Dose | Administration Frequency | Typical GH Pulse Amplitude (vs Baseline) | Fat Loss Efficacy (12-Week Studies) | Best Use Case | Bottom Line ||—|—|—|—|—|—|| Monotherapy (no GHS stack) | 300mcg total (100mcg × 3) | 3× daily (fasted AM, pre-meal, bedtime) | 1.8–2.4× baseline | Moderate (6–8% body fat reduction) | Budget-conscious researchers, mild deficits | Suboptimal. Requires GHS for maximal effect || Standard Stack (with ipamorelin) | 300mcg CJC + 300–600mcg ipamorelin | 3× daily (same timing) | 4.2–6.8× baseline | High (12–18% body fat reduction) | Most researchers, first cycles | Gold standard. Best efficacy-to-side-effect ratio || Aggressive Stack (with GHRP-2) | 300mcg CJC + 400–600mcg GHRP-2 | 3× daily (same timing) | 5.1–8.2× baseline | Very High (15–22% body fat reduction) | Experienced users, short cycles (8–12 weeks) | Maximum effect but cortisol risk in sensitive individuals || Single Daily Dose | 200–300mcg | 1× daily (bedtime only) | 3.1–4.2× baseline
More references

Related material